Skip to content
XPR
content.
Press releases
Video
Podcasts
Op-eds
Lists
Guest posts
Author:
Vicore Pharma Holding
Vicore Pharma to Present at The Pareto Securities 17th Annual Healthcare Conference
August 26, 2026
Vicore Pharma to Present at the European Respiratory Society Congress 2026
August 24, 2026
Vicore Pharma to Participate in the Leerink Therapeutics Forum
July 7, 2026
Vicore Pharma Appoints Rob Slack as Chief Scientific Officer
July 6, 2026
Vicore Pharma to Commence Trading in the United States on the Nasdaq Stock Market
July 1, 2026
Vicore Pharma to Host Webcast to Discuss Buloxibutid and the Evolving IPF Treatment Landscape
June 2, 2026